Discover
Share the concern, treatment area and change you would like to explore
Loading
Please wait while the page content is assembled.


WEGOVY is a prescription medicine containing semaglutide. It is a GLP-1 receptor agonist used for eligible adults within a complete medical weight-management programme. It is not an over-the-counter product or a wellness supplement.
WEGOVY is a prescription medicine containing semaglutide. It is a GLP-1 receptor agonist used for eligible adults within a complete medical weight-management programme. It is not an over-the-counter product or a wellness supplement.
01 / How it works
What is WEGOVY? It is a brand-specific prescription medicine containing the active ingredient semaglutide, which acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. WEGOVY acts on GLP-1 receptors involved in appetite, fullness, and food-intake regulation. It also delays gastric emptying. By helping suitable patients feel fuller, it can reduce energy intake when used alongside a medical nutrition and physical activity plan.
It is crucial to understand that WEGOVY is not a fat-burning injection, insulin, or a localised cosmetic treatment for facial slimming or abdominal fat dissolving. It works systemically throughout the body. Furthermore, WEGOVY is not the same as Ozempic, Rybelsus, Mounjaro, or Saxenda. While some contain the same ingredient, they are separate registered brands with unique indications. Patients visiting us from Eko Galleria, Eco Botanic, and Singapore appreciate our transparent approach: we educate you on how semaglutide supports chronic weight management without relying on unrealistic “instant slimming” claims.
WEGOVY is a prescription medicine containing semaglutide. It is a GLP-1 receptor agonist used for eligible adults within a complete medical weight-management programme. It is not an over-the-counter product or a wellness supplement.
Share the concern, treatment area and change you would like to explore
Shape the approach around your features, preferences and schedule
Experience a carefully planned session with clear guidance throughout
Follow simple aftercare and review how the treatment is progressing

02 / Visual guide
WEGOVY is a prescription medicine containing semaglutide. It is a GLP-1 receptor agonist used for eligible adults within a complete medical weight-management programme. It is not an over-the-counter product or a wellness supplement.
Interactive treatment map
Tap a numbered point to move from your concern to the treatment approach, how it works and a personalised plan.

Start with the change you have noticed and the result you would like to explore.
Concerns & areas
Explore common areas and goals, then discuss which are most relevant to you.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Who may benefit
Your answers suggest that a doctor-supervised weight-management consultation may help assess your eligibility, weight-related health concerns, and long-term goals. Medi Clinic can verify genuine Malaysian-registered WEGOVY and explain realistic benefits and monitoring.
What to discuss first
03 / Your treatment journey
A calm, well-explained experience at every stage.
Talk through the concern, your previous experiences and the result you would like to explore.
Review the treatment area, suitable options, expected experience and practical timing.
Arrive prepared and receive clear guidance throughout the treatment visit.
Leave with simple aftercare, helpful contact details and a plan for review.
The surgical and anaesthesia teams must be informed because WEGOVY delays stomach emptying, which may increase aspiration risk during deep sedation. The prescribing doctor and procedural team should make a patient-specific plan.
04 / Practical expectations
Your experience will reflect the selected treatment, treatment area and individual response. These are the useful details to explore during your visit.
05 / Compare your options
Compare the treatment approach, the area it is designed for, the experience and the way results may develop—not only the name or price.
A useful starting point when you already know the treatment and want to understand it more clearly.
Opens a wider conversation about suitable approaches, timing, recovery and natural-looking results.
Treatment gallery
Explore the consultation, treatment setting and preparation through a carefully selected visual story.
Related concerns
Begin with the concern you notice, then discover treatment approaches and questions worth bringing to your consultation.
Patient knowledge guide
Four short questions explain the treatment, suitability and why assessment matters. This quiz educates—it does not diagnose or confirm treatment eligibility.
06 / Before you decide
If WEGOVY is deemed medically appropriate, it is vital to understand the associated risks. Gastrointestinal effects are common, including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort.
Severe Risks & Monitoring: We educate you on urgent warning signs. Severe, persistent abdominal pain requires immediate medical assessment as it may indicate acute pancreatitis. Prolonged vomiting can cause dehydration and affect kidney function. We also evaluate the risk of gallbladder disease, diabetic retinopathy changes, and hypoglycaemia especially if you use insulin or sulfonylureas. Additionally, due to delayed stomach emptying, you must inform surgeons and anaesthetists that you are taking a GLP-1 medicine before any procedure involving anaesthesia or deep sedation. Our patients from Tebrau, Permas Jaya, and Singapore trust us to monitor their health diligently throughout their treatment journey.
Read about informed consent07 / Recovery
You will receive treatment-specific guidance on what to expect, how to care for the area and when to contact the clinic with a question.
Contact the clinic08 / FAQ
Helpful answers for planning your consultation and understanding the treatment experience.
WEGOVY is a prescription medicine containing semaglutide. It is a GLP-1 receptor agonist used for eligible adults within a complete medical weight-management programme. It is not an over-the-counter product or a wellness supplement.
No. While WEGOVY and Ozempic both contain semaglutide, they are separate registered brands with different indications and treatment instructions. Mounjaro contains tirzepatide, a different active ingredient. They are not automatically interchangeable.
No. It does not directly burn or dissolve fat, nor can it target isolated areas like the abdomen or thighs. It is a systemic medicine used to manage chronic obesity by acting on the brain to regulate appetite and food intake.
Because obesity is a chronic condition, appetite and weight may increase again after stopping treatment. Maintenance planning should be carefully discussed with the prescribing doctor to build sustainable long-term habits.
The surgical and anaesthesia teams must be informed because WEGOVY delays stomach emptying, which may increase aspiration risk during deep sedation. The prescribing doctor and procedural team should make a patient-specific plan.
Prescription medicine should only be obtained through authorised medical channels. Avoid social-media sellers, compounded mixtures, or unlabelled pens, as they pose serious health risks and lack local NPRA verification.
Plan your next step
Share your goals with the Eco Botanic team and begin with a personalised consultation.